Current Medical and Surgical Therapy for Cerebrovascular Disease

Publisher Website
Google Scholar
Abstract
THE past several years have witnessed a flurry of prospective clinical trials of new treatments for transient ischemic attack, cerebral infarction, and cerebral hemorrhage, and the results have markedly altered our management of these conditions (Table 1). Furthermore, another generation of Phase II and controlled prospective studies (based on pilot studies) are planned or under way (Table 2). This survey will briefly review these studies in the context of current therapy for the following: prevention of stroke after transient ischemic attack or stroke, acute cerebral infarction and progressing stroke, cardiogenic embolism to the brain, cerebral arteritis, intracerebral hematoma, arteriovenous malformation, . . .

This publication has 95 references indexed in Scilit: